SCHEMBL6203740

SCHEMBL6203740

CCCCCNc1nc(C)c(-c2ccc(C(F)(F)F)cc2Cl)nc1OC

nearest known ligand 0.54

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 19/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7472159 0.90 CRHR1 (0.54) CRHR1
SCHEMBL6204026 0.86 CRHR1 (0.41) CRHR1
SCHEMBL7484320 0.84 CRHR1 (0.50) CRHR1
SCHEMBL6199780 0.83 CRHR1 (0.40) CRHR1
SCHEMBL7475201 0.83 CRHR1 (0.68) CRHR1
SCHEMBL7474607 0.83 CRHR1 (0.60) CRHR1
SCHEMBL5432945 0.82 CRHR1 (0.79) CRHR1
SCHEMBL6205812 0.81 CRHR1 (0.45) CRHR1
SCHEMBL7471605 0.79 CRHR1 (0.51) CRHR1
SCHEMBL7477544 0.78 CRHR1 (0.55) CRHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1554258-A1 5-SUBSTITUTED-2-ARYLPYRAZINES AS MODULATORS OF CRF RECEPTORS NEUROGEN CORPORATION (US) 2005-07-20 EP claimed
WO-2004018437-A1 5-SUBSTITUTED-2-ARYLPYRAZINES AS MODULATORS OF CRF RECEPTORS NEUROGEN CORPORATION (US) 2004-03-04 WO claimed